SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Schedule 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
CYBERONICS, INC.
----------------------
(Name of Issuer)
Common Stock, $0.01 par value
-----------------------------------
(Title of Class of Securities)
23251P-10-2
----------------------
(CUSIP Number)
Kevin T. O'Malley
Vice President and General Counsel
St. Jude Medical, Inc.
One Lillehei Plaza
St. Paul, MN 55117
Telephone: (651) 483-2000
---------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
February 9, 2000
---------------------------------------------
(Date of Event which Requires Filing of this Statement)
-------------------------------------------------------------------------
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following
box. | |
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 4
<PAGE>
CUSIP No. 23251P-10-2
1 NAMES OF REPORTING PERSONS, I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
(Entities Only)
St. Jude Medical, Inc.
41-1276891
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [ ]
(b) [X]
3 SEC USE ONLY
4 SOURCE OF FUNDS (See Instructions) N/A
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e) [ ]
6 CITIZENSHIP OR PLACE OF ORGANIZATION MINNESOTA
NUMBER OF 7 SOLE VOTING POWER 921,718
SHARES
BENEFICIALLY 8 SHARED VOTING POWER - 0 -
OWNED BY EACH
REPORTING 9 SOLE DISPOSITIVE POWER 921,718
PERSON WITH:
10 SHARED DISPOSITIVE POWER - 0 -
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 921,718
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES (See Instructions) [ ]
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 5.07%
14 TYPE OF REPORTING PERSON (See Instructions) CO
Page 2 of 4
<PAGE>
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(c) The purpose of this filing is to report various sales by St. Jude
Medical, Inc. of an aggregate 130,100 shares of Common Stock of Cyberonics, Inc.
("Cyberonics") in December 1999 and February 2000. The sales were effected in
open market transactions. Cyberonics' shares are traded on the Nasdaq National
Market. As a result of the sales, the remaining 921,718 shares beneficially
owned by St. Jude Medical, Inc. represent approximately 5.07% of the currently
outstanding shares of Common Stock of Cyberonics. St. Jude Medical, Inc. has
sole voting and dispositive power with respect to all of the shares of Common
Stock of Cyberonics that it owns. Set forth below are the respective sales of
Common Stock of Cyberonics made by St. Jude Medical, Inc. in December 1999 and
February 2000:
No. of
Date Shares Sold Price Per Share
---- ----------- ---------------
12/9/99 10,000 $16.88
12/10/99 25,000 17.03
12/13/99 30,000 16.53
12/14/99 15,100 16.65
02/09/00 50,000 26.64
-------
130,100
=======
Remaining Shares Held: 921,718 (5.07%)
=======
Page 3 of 4
<PAGE>
Signature
After reasonable inquiry and to the best of its knowledge and belief,
the undersigned certifies that the information set forth in this statement is
true, complete and correct.
Dated: March 10, 2000
ST. JUDE MEDICAL, INC.
By: \s\ Kevin T. O'Malley
----------------------------------
Kevin T. O'Malley
Vice President and General Counsel
Page 4 of 4
